A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 21, Issue 5, 2008, Pages 430-436

  Yamashita, H ^a   Nakagawa, K ^a   Yamada, K ^a   Kaminishi, M ^a   Mafune, K ^a   Ohtomo, K ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chemoradiotherapy; Combined modality therapy; Esophageal cancer; Squamous cell carcinoma; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CHEMOTHERAPY INDUCED EMESIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG FATALITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INFECTION; INTERMETHOD COMPARISON; JAPANESE; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; OVERALL SURVIVAL; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PHARYNGITIS; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; STOMATITIS; SURGICAL PATIENT; SURVIVAL RATE; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 48649090671     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00793.x     Document Type: Article

References (29)

1. Jemal A, Tiwari R C, Murray T et al. Cancer statistics. CA Cancer J Clin 2004; 54: 8-29.
2. Health and Welfare Statistics Association. J Health Welfare Statistics 2003; 50: 406-13. [in Japanese].
3. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-32.
4. Rice T W, Adelstein D J, Chidel M A et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003; 126: 1590-6.
5. Malthaner R A, Wong R K, Rumble R B, Zuraw L. Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med 2004; 2: 35.
6. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 372-3.
7. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
8. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-7.
9. Araujo C M, Souhami L, Gil R A et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991; 67: 2258-61.
10. Wilson K S, Lim J T. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: Goal of cure with organ preservation. Radiother Oncol 2000; 54: 129-34.
11. Muller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57. [Review].
12. Wobst A, Audisio R A, Colleoni M, Geraghty J G. Oesophageal cancer treatment: Studies, strategies and facts. Ann Oncol 1998; 9: 951-62. [Review].
13. Chiu P W, Chan A C, Leung S F et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005; 9: 794-802.
14. Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
15. Cox J D, Stetz J, Pajak T F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
16. Hironaka S, Ohtsu A, Boku N et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3) N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425-33.
17. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999; 45: 265-70.
18. Shepherd NA. Barrett's esophagus: Its pathology and neoplastic complications. Esophagus 2003; 1: 17-29.
19. Registration Committee for Esophageal Cancer. In: Comprehensive Registry of Esophageal Cancer in Japan (1978). Tokyo: Japanese Society for Esophageal Diseases and National Cancer Center, 1983. [in Japanese].
20. Registration Committee for Esophageal Cancer. In: Comprehensive Registry of Esophageal Cancer in Japan (1988-94). Tokyo: Japanese Society for Esophageal Diseases, 1998. [in Japanese].
21. Registration Committee for Esophageal Cancer. In: Comprehensive Registry of Esophageal Cancer in Japan (1998-99) and Long-Term Results of Esophagoectomy in Japan (1988-97), 3rd edn. Tokyo: Japanese Society for Esophageal Diseases, 2002.
22. Fujita H. Present status of esophageal cancer and its treatment in Japan. Ann Thorac Cardiovasc Surg 2004; 10: 135-9. [Editorial].
23. Daly J M, Karnell L H, Menck H R. National Cancer Data Base report on esophageal carcinoma. Cancer 1996; 78: 1820-8.
24. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
25. Ando N, Iizuka T, Ide H et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21: 4592-6.
26. Coia LR. Chemoradiation: A Superior Alternative for the Primary Management of Esophageal Carcinoma. Semin Radiat Oncol 1994; 4: 157-64.
27. Bonnetain F, Bouche O, Michel P et al. Radomized phase III trial in locally advanced esopjaheal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD9102). Proc Am Soc Clin Oncol 2002; 21: 130a.
28. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-7.
29. Burmeister B H, Smithers B M, Gebski V et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer for the esophagus: A randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-68.